105 related articles for article (PubMed ID: 4370090)
1. Implications of secretory immune system in viral infections.
Ogra PL; Wallace RB; Umana G; Ogra SS; Grant DK; Morag A
Adv Exp Med Biol; 1974; 45(0):271-82. PubMed ID: 4370090
[No Abstract] [Full Text] [Related]
2. Immunoprophylaxis of viral infections in childhood.
Ogra PL
Indian J Pediatr; 1970 Aug; 37(271):376-94. PubMed ID: 4099208
[No Abstract] [Full Text] [Related]
3. Immune response to acute otitis media in children III. Implications of viral antibody in middle ear fluid.
Sloyer JL; Howie VM; Ploussard JH; Bradac J; Habercorn M; Ogra PL
J Immunol; 1977 Jan; 118(1):248-50. PubMed ID: 187700
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
[TBL] [Abstract][Full Text] [Related]
5. Determination of measles, mumps, and rubella immunization status using oral fluid samples.
Thieme T; Piacentini S; Davidson S; Steingart K
JAMA; 1994 Jul; 272(3):219-21. PubMed ID: 8022041
[TBL] [Abstract][Full Text] [Related]
6. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
[TBL] [Abstract][Full Text] [Related]
7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
8. Immunologic and virologic aspects of secretory immune system in human respiratory tract.
Ogra PL; Morag A
Dev Biol Stand; 1975; 28():129-44. PubMed ID: 47823
[TBL] [Abstract][Full Text] [Related]
9. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
[No Abstract] [Full Text] [Related]
11. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
Just M; Berger R; Just V
Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
[TBL] [Abstract][Full Text] [Related]
13. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
Narayan KM; Moffat MA
Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
[TBL] [Abstract][Full Text] [Related]
14. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE
J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
Glikmann G; Petersen I; Mordhorst CH
Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
[TBL] [Abstract][Full Text] [Related]
19. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
Krober MS; Stracener CE; Bass JW
JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
[TBL] [Abstract][Full Text] [Related]
20. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
André FE; Peetermans J
Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
